Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Overview of attention for article published in New England Journal of Medicine, August 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news: 15 news outlets
blogs: 3 blogs
twitter: 536 X users

facebook: 6 Facebook pages
wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 282 Dimensions

Readers on

mendeley: 373 Mendeley

Summary News Blogs X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

Zackary Berger’s journal reviews—8 October 2018

Latest BMJ blogs, 08 Oct 2018

Zackary Berger reviews the latest research from the top medical…

NEJM: Rivaroxaban (XARELTO®) For Thromboembolism Prevention after Medical Illness

MedicalResearch.com, 04 Oct 2018

MedicalResearch.com Interview with: Dr.

Rivaroxaban senkt Mortalität bei Herzinsuffizienz und Sinusrhythmus nicht

medONLINE, 28 Aug 2018

Der Gerinnungshemmer kann Mortalität und schwere thrombotische Ereignisse bei Patienten mit Herzinsuffizienz im Sinusrhythmus…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.